Search by Drug Name or NDC
NDC 00781-6184-87 Tafluprost 0.0045 mg/.3mL Details
Tafluprost 0.0045 mg/.3mL
Tafluprost is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sandoz Inc. The primary component is TAFLUPROST.
MedlinePlus Drug Summary
Tafluprost ophthalmic is used to treat glaucoma (a condition in which increased pressure in the eye can lead to gradual loss of vision) and ocular hypertension (a condition which causes increased pressure in the eye). Tafluprost is in a class of medications called prostaglandin analogs. It lowers pressure in the eye by increasing the flow of natural eye fluids out of the eye.
Related Packages: 00781-6184-87Last Updated: 02/05/2023
MedLinePlus Full Drug Details: Tafluprost Ophthalmic
Product Information
| NDC | 00781-6184 |
|---|---|
| Product ID | 0781-6184_bfffa484-4105-45ec-ab1d-124e96639f35 |
| Associated GPIs | |
| GCN Sequence Number | 065587 |
| GCN Sequence Number Description | tafluprost/PF DROPERETTE 0.0015 % OPHTHALMIC |
| HIC3 | Q6G |
| HIC3 Description | MIOTICS AND OTHER INTRAOCULAR PRESSURE REDUCERS |
| GCN | 27594 |
| HICL Sequence Number | 036600 |
| HICL Sequence Number Description | TAFLUPROST/PF |
| Brand/Generic | Generic |
| Proprietary Name | Tafluprost |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Tafluprost |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 0.0045 |
| Active Ingredient Units | mg/.3mL |
| Substance Name | TAFLUPROST |
| Labeler Name | Sandoz Inc |
| Pharmaceutical Class | Increased Prostaglandin Activity [PE], Prostaglandin Analog [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA209040 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00781-6184-87 (00781618487)
| NDC Package Code | 0781-6184-87 |
|---|---|
| Billing NDC | 00781618487 |
| Package | 6 POUCH in 1 CARTON (0781-6184-87) / 5 CONTAINER in 1 POUCH (0781-6184-14) / .3 mL in 1 CONTAINER |
| Marketing Start Date | 2022-12-05 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 4.22022 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | TAFLUPROST 0.0015% EYE DROP |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis